An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The focus of this project is cardiovascular diabetic autonomic neuropathy (DAN). DAN affects
the nerves that control heart rate and blood flow to the heart in people with diabetes. DAN
may cause problems with the rhythm of the heartbeat or decrease blood flow to the heart.
Three medications will be tested for their effectiveness in DAN.